Galderma Group AG
GALD
Rang in Aktien
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aktienkurs
$224.81
Marktkapitalisierung
$52.42B
Veränderung (1 Tag)
6.31%
Veränderung (1 Jahr)
31.28%
Land
CH
Handel Galderma Group AG (GALD)
Kategorie
Healthcare
Kursverlauf für Galderma Group AG (GALD)
Höchster Schlusskurs: $217.37 am 2026-10-01
Niedrigster Schlusskurs: $68.55 am 2024-03-01
Niedrigster Schlusskurs: $68.55 am 2024-03-01
Kursverlauf der Aktie von Galderma Group AG von 2024 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 0.90% |
| 2025 | 96.13% |
| 2024 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $18.43 | -4.03% |
IN
|
|
| $6.89 | -24.78% |
CN
|
